Authors
Latest:
How the Pandemic Changed PharmaciesPharmacists have been increasingly recognized as key partners in the clinical services needed to manage the pandemic.
Latest:
Understand the Effects of Topical Nasal Decongestants on Blood PressureBecause decongestants act by constricting blood vessels, their use can be problematic in individuals who have hypertension.
Latest:
Advice for Physicians to Manage C. Difficile Infection (CDI)Experts share advice for physicians taking care of patients with C. difficile infection (CDI).
Latest:
Asembia AXS25: Digital Pharmacy Strategies for Patient-Centered CareDigital pharmacy solutions are revolutionizing patient care.
Latest:
Postpandemic Future Is Bright for TechniciansTapping techs as immunizers opens up greater visibility and new source of health care labor.
Latest:
Tip of the Week: The Benefits of Mentoring Can Extend to Everyone InvolvedMentorship is a long-term and formative process and interaction that extends beyond initial discussions regarding the mentee's career path.
Latest:
The Role of Behavioral Economics in Smoking CessationBehavioral economics is a tool that can influence patient behaviors using concepts such as choice architecture, nudges, and loss aversion.
Latest:
Multiple Myeloma Therapy Often Causes Cardiovascular ComplicationsMany patients have baseline risk factors present at diagnosis because of older age and disease-related elements.
Latest:
Vermont’s Prescribed Products Gift Ban and Disclosures ActThe law has impacted the number of physicians receiving payment from drug companies.
Latest:
Key Takeaways on FMTs in the Treatment of CDIExperts provide practice pearls for educating patients on and using FMTs for the management of CDI.
Latest:
Does Corticosteroid Use Have a Role in Severe Community-Acquired Pneumonia?Since the most recent guidelines were published, more evidence has emerged regarding intravenous corticosteroids for severely ill patients.
Latest:
EHA 2025: No Added Toxicity Observed With Bleximenib Plus Venetoclax and Azacitidine in AMLAndrew H. Wei, PhD, discusses phase 1b findings on the safety, pharmacokinetics, and preliminary efficacy of combining the menin inhibitor bleximenib with venetoclax and azacitidine in patients with newly diagnosed or relapsed/refractory acute myeloid leukemia (AML) harboring NPM1 mutations or KMT2A rearrangements.
Latest:
Clinical Overview: Finerenone (Kerendia) Lowers Cardiovascular Events, Chronic Kidney Disease ProgressionFinerenone is a first in class nonsteroidal mineralocorticoid receptor antagonist indicated in adults with chronic kidney disease associated with type 2 diabetes mellitus.
Latest:
Prevalence of Dosage Modifications and Impact on Response Milestone Among Patients With CML Treated With Imatinib Using RWDThis abstract will be presented at the Oncology Pharmacists Connect (OPC) meeting in Austin, Texas, from June 19 to 20, 2025.
Latest:
Technology Can Help Ease Provider Burnout, Access to Health CareThe need for pharmacists to return to a more clinically-focused role became apparent as the COVID-19 pandemic revealed gaps in patient access to care across the country.
Latest:
Trends in Emergency Department Follow-Up ProgramsPharmacy personnel can be integrated to optimize antimicrobial use.
Latest:
Optimizing Self-Management for Outpatient Pharmacy Patients With DiabetesThe use of outpatient pharmacy protocols for glucose testing and insulin administration supplies should be expanded to assist patients in the self-management of diabetes.
Latest:
Navigating the Shadows: Understanding the Psychology and Pharmacology of Treating Postpartum DepressionA new treatment for postpartum depression has been developed with rapid onset, cutting down the time it has taken previous treatments to take effect by weeks or months.
Latest:
Wellness Support Group Shows Promise in Reducing BurnoutDiscussions are led by a variety of experienced preceptors to provide insight, strategies, and resources for pharmacy residents.
Latest:
Driving Clinical Pharmacy Development With Data-Driven Metrics and InsightsThere are no clearly defined, widely accepted clinical pharmacist metrics.
Latest:
How PBMs Can Help Rein in Drug SpendingFormulary changes, utilization management, and a lack of transparency upset a lot of members, which hides a lot of good things that pharmacy benefit managers do.
Latest:
Asembia AXS25: Cardinal Health Transforms Cold Chain Logistics for Emerging TherapiesCardinal Health is investing in cold chain logistics and packaging solutions to expedite the delivery of novel therapies from FDA approval to patient access.
Latest:
What Pharmacists Need to Know About Omega-3 Fatty Acids and Fish Oil SupplementsMany patients turn to fish oil supplements to gain the benefits of omega-3 fatty acids, but there are important considerations pharmacists should be aware of before recommending fish oil supplements to their customers.
Latest:
Behind the Counter: Mastering Pseudoephedrine and Other Restricted OTC MedicationsMelissa Zinszer, PharmD, CDCES, explores the multifaceted role of pharmacists and healthcare providers in managing behind-the-counter medications, addressing patient concerns, optimizing over-the-counter therapy, and ensuring safe, effective treatment through careful symptom assessment and consideration of drug interactions.
Latest:
New Tool Helps Providers Navigate Adalimumab BiosimilarsThe tool consolidates and highlights key features that would be considered when choosing a biosimilar adalimumab.
Latest:
Preventing Adverse Drug Events: A Call to Action for PharmacistsNational Adverse Drug Event Awareness Day was established to promote awareness, drive policy changes, and encourage health care professionals and patients to prioritize medication safety.
Latest:
Explore Ovarian Cancer Treatments Through Clinical TrialsGuidelines typically recommend debulking surgery, plus systemic chemotherapy for most patients.
Latest:
Oral Oncolytics Expand Armamentarium in HR+/HER– Early-Stage Breast Cancer in Adjuvant SettingNew agents can offer a more tailored approach to therapy selection.
